Search Results

There are 37600 results for: content related to: Infected Bilomas in Liver Transplant Recipients, Incidence, Risk Factors and Implications for Prevention

  1. Ursodeoxycholic acid for primary biliary cirrhosis

    Intervention Review

    The Cochrane Library

    Jelena S Rudic, Goran Poropat, Miodrag N Krstic, Goran Bjelakovic and Christian Gluud

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD000551.pub3

  2. You have free access to this content
    Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 8, August 1999, Pages: 979–995, Trauner and Graziadei

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00596.x

  3. Biotransformation of orally administered ursodeoxycholic acid in man as observed in gallbladder bile, serum and urine

    European Journal of Clinical Investigation

    Volume 23, Issue 1, January 1993, Pages: 28–36, S. FISCHER, M. NEUBRAND and G. PAUMGARTNER

    Version of Record online : 20 MAR 2008, DOI: 10.1111/j.1365-2362.1993.tb00714.x

  4. You have free access to this content
    Ursodeoxycholic acid — adverse effects and drug interactions

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 10, November 2003, Pages: 963–972, W. Hempfling, K. Dilger and U. Beuers

    Version of Record online : 14 NOV 2003, DOI: 10.1046/j.1365-2036.2003.01792.x

  5. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration

    Hepatology

    Volume 14, Issue 6, December 1991, Pages: 1000–1007, Andrea Crosignani, Mauro Podda, Pier Maria Battezzati, Emanuela Bertolini, Massimo Zuin, David Watson and Kenneth D. R. Setchell

    Version of Record online : 8 DEC 2005, DOI: 10.1002/hep.1840140609

  6. You have free access to this content
    Ursodeoxycholic acid has no influence on function after restorative proctocolectomy in ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 12, December 1999, Pages: 1593–1596, Tan, Morton, Bain and Keighley

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00665.x

  7. You have free access to this content
    Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocytes

    BJOG: An International Journal of Obstetrics & Gynaecology

    Volume 110, Issue 5, May 2003, Pages: 467–474, J. Gorelik, A.I. Shevchuk, I. Diakonov, M. de Swiet, M. Lab, Y. Korchev and C. Williamson

    Version of Record online : 22 DEC 2003, DOI: 10.1046/j.1471-0528.2003.02273.x

  8. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

    Hepatology

    Volume 17, Issue 4, April 1993, Pages: 577–582, Renée E. Poupon, Khadija Ouguerram, Yves Chrétien, Claudine Verneau, Eveline Eschwège, Thierry Magot and Raoul Poupon

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840170408

  9. Ursodeoxycholic acid therapy in cystic fibrosis—associated liver disease: A dose-response study

    Hepatology

    Volume 16, Issue 4, October 1992, Pages: 924–930, Carla Colombo, Andrea Crosignani, Marisa Assaisso, Pier Maria Battezzati, Mauro Podda, Annamaria Giunta, Linda Zimmer-Nechemias and Kenneth D. R. Setchell

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840160412

  10. You have free access to this content
    Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: A population-based cohort study

    Hepatology

    Volume 46, Issue 4, October 2007, Pages: 1131–1137, Hannah Jackson, Masoud Solaymani-Dodaran, Tim R. Card, Guruprasad P. Aithal, Richard Logan and Joe West

    Version of Record online : 8 AUG 2007, DOI: 10.1002/hep.21795

  11. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics

    European Journal of Clinical Investigation

    Volume 16, Issue 2, April 1986, Pages: 169–177, BO ANGELIN, KLAS NILSELL and KURT EINARSSON

    Version of Record online : 20 MAR 2008, DOI: 10.1111/j.1365-2362.1986.tb01325.x

  12. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: Comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid

    Hepatology

    Volume 14, Issue 6, December 1991, Pages: 1136–1141, Michael Sackmann, Juergen Pauletzki, Uelker Aydemir, Joseph Holl, Tilman Sauerbruch, Joerg Hasford and Gustav Paumgartner

    Version of Record online : 8 DEC 2005, DOI: 10.1002/hep.1840140630

  13. Bezafibrate for primary biliary cirrhosis

    Intervention Review

    The Cochrane Library

    Jelena S Rudic, Goran Poropat, Miodrag N Krstic, Goran Bjelakovic and Christian Gluud

    Published Online : 18 JAN 2012, DOI: 10.1002/14651858.CD009145.pub2

  14. You have free access to this content
    Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study

    Alimentary Pharmacology & Therapeutics

    Volume 11, Issue 2, April 1997, Pages: 409–414, A. LARGHI, A. CROSIGNANI, P. M. BATTEZZATI, G. DE VALLE, M. ALLOCCA, P. INVERNIZZI, M. ZUIN and M. PODDA

    Version of Record online : 2 OCT 2003, DOI: 10.1046/j.1365-2036.1997.124295000.x

  15. The major metabolites of ursodeoxycholic acid in human urine are conjugated with N-acetylglucosamine

    Hepatology

    Volume 20, Issue 4, October 1994, Pages: 845–853, Dr. Hanns-Ulrich Marschall, William James Griffiths, Ulrich Götze, Jie Zhang, Hubertus Wietholtz, Norbert Busch, Jan Sjövall and Siegfried Matern

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840200412

  16. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis

    Hepatology

    Volume 10, Issue 4, October 1989, Pages: 414–419, Dr. Ashok K. Batta, Gerald Salen, Renu Arora, Sarah Shefer, G. Stephen Tint, John Abroon, David Eskreis and Seymour Katz

    Version of Record online : 6 DEC 2005, DOI: 10.1002/hep.1840100404

  17. You have free access to this content
    Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: A randomized placebo-controlled treatment trial

    Hepatology

    Volume 30, Issue 6, December 1999, Pages: 1381–1386, Albert J. Czaja, Herschel A. Carpenter and Keith D. Lindor

    Version of Record online : 30 DEC 2003, DOI: 10.1002/hep.510300603

  18. Immunomodulatory effects of ursodeoxycholic acid on immune responses

    Hepatology

    Volume 16, Issue 2, August 1992, Pages: 358–364, Masahide Yoshikawa, Tadasu Tsujii, Keisuke Matsumura, Junnichi Yamao, Yoshinobu Matsumura, Ryouichi Kubo, Hiroshi Fukui and Shigeaki Ishizaka

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840160213

  19. You have free access to this content
    Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor

    Allergy

    Volume 67, Issue 12, December 2012, Pages: 1501–1510, M. A. M. Willart, M. van Nimwegen, A. Grefhorst, H. Hammad, L. Moons, H. C. Hoogsteden, B. N. Lambrecht and A. KleinJan

    Version of Record online : 25 SEP 2012, DOI: 10.1111/all.12019

  20. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease

    Hepatology

    Volume 15, Issue 4, April 1992, Pages: 603–608, Ulrich Beuers, Ulrich Spengler, Franz M. Zwiebel, Juergen Pauletzki, Sven Fischer and Gustav Paumgartner

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840150409